The 14-day incidence rate continues its downward trend and this Tuesday stood at 233.75 cases per 100,000 inhabitants, a drop of eight points compared to Monday. The contagion rate has dropped continuously since July 27, more than a month ago, when the peak incidence of the fifth wave was reached, in 702 cases. Yesterday, Spain came out of the extreme risk of contagion, after descending the barrier of 250 cases.
The incidence is low in all the communities except Andalusia, Aragón and Euskadi. Castilla y León and Cantabria have updated the data since Friday, because yesterday, due to technical problems in the first case and a holiday in the second, no new figures were included.
The contagion rate, of course, rises among the youngest for the first time in more than a month. In the group from 20 to 29, the incidence goes from 312 to 337 cases per 100,000 inhabitants and in the group from 12 to 19 from 417 to 461 in the last day.
The Ministry of Health has reported 194 new deaths in the last 24 hours, a figure comparable to that of Friday, since all weekend cases are counted on Mondays. In total, 84,340 people have died from COVID-19 since the start of the pandemic. The figure is the highest in the fifth wave, although the calculation includes data accumulated since Friday from the two communities that did not update their figures on Monday.
It continues to decline despite hospital pressure. Those admitted to ICUs went from 1,652 on Monday to 1,571 this Tuesday, bringing the occupation of intensive therapies with COVID patients to 17.39%. Hospitalizations in conventional beds with patients with this pathology also decrease. Occupancy is 5.80%.
The authorities have also recorded 7,767 new infections in the last day, a decrease from those reported on Friday. In total, 4,855,065 people have been infected by COVID-19 since the start of the health crisis.
The communities that register the highest number of new infections are Catalonia, which totals 1,123; Madrid, which scores 1,083; and Castilla y León, with 1,082 new cases.
Five reasons why it is not justified, for now, to give third doses of vaccines to the general population
For a few months, the directors of various pharmaceutical companies responsible for the production and marketing of vaccines against COVID-19 have been repeatedly communicating to the media the alleged importance of administering third booster doses to the general population to avoid attenuation of the immune response against SARS-CoV-2. The director of Pfizer, Albert Bourla, reiterated this idea in an interview with the half Business Insider just a few days ago. Bourla explained that “the most likely scenario is that we will need annual revaccination, as we do with the flu vaccine.” Some countries, like Israel, carry and at some time administering third doses to the general population, as a strategy to stop the increase in infections among its population.
So far, no pharmaceutical company has applied for emergency authorization of booster doses for the general population from drug agencies, including both the European Medicines Agency (EMA), and the United States Food and Drug Administration (FDA ). However, Pfizer has announced that it expects to complete its request for a third dose later this week.